Village Farms International Reports Q4 and Full Year 2024 Results: A Look Ahead to 2025

The fourth quarter of 2024 saw consolidated sales increase by 11% to $82.6 million, up from $74.2 million in the same quarter of 2023. However, the results were heavily influenced by a $10.5 million (C$15.0 million) non-cash impairment charge related to non-flower inventory in Canadian Cannabis, which management deemed did not meet quality standards. Excluding this impairment, the consolidated Adjusted EBITDA would have been $7.0 million for Q4 and $12.2 million for the full year.

In the Canadian Cannabis sector, net sales were up 10% to C$48.0 million, driven by a remarkable 127% increase in international medicinal sales. However, the gross margin was adversely affected by the impairment charge, falling to 2% compared to 23% in Q4 2023. Excluding the impairment, gross margin would have been a healthy 33%.

Village Farms remains a top three producer in Canada, with significant market share in dried flower and pre-roll categories. The company also launched several new products, including the Super Toast All-In-One Vape and the Canna Czar specialty blunt.

The U.S. Cannabis segment, which includes Balanced Health Botanicals, reported net sales of $4.6 million, a slight decline from $5.1 million in Q4 2023. Notably, this segment achieved a gross margin of 70%, reflecting operational efficiencies.

The Fresh Produce segment saw sales rise by 17% to $43.3 million, with net income of $1.9 million, a remarkable turnaround from a net loss of $7.0 million in the same period last year.

Michael DeGiglio, President and CEO, expressed optimism regarding the company’s path forward, stating, “Over the past three years, we have organically grown our Canadian Cannabis business into a perennial market share leader and one of the only operators with a track record of positive cash flow from operations.” He emphasized the company's efforts to optimize resources and inventory to focus on more profitable growth opportunities, both domestically and internationally.

DeGiglio highlighted the strong demand for international sales, particularly in Germany, Australia, and the UK, and expressed confidence in the company's ability to triple international medicinal export sales in 2025.

Village Farms is set to optimize its Canadian Cannabis resources through operational efficiencies between its Pure Sunfarms and Rose subsidiaries. The company has also broken ground on a Phase II expansion at its Leli Holland subsidiary in the Netherlands, which is expected to quintuple annual production capacity by Q4 2025.

DeGiglio noted, “We believe we are well positioned to execute and deliver a successful year of profitable growth in 2025 and beyond,” underscoring the potential for transformative developments in the coming year.

Despite facing hurdles in Q4 2024, Village Farms International appears poised for a promising 2025. With strategic initiatives in place, a strong international sales pipeline, and a focus on operational efficiencies, the company aims to solidify its position as a leader in the cannabis and fresh produce markets. Investors and analysts alike will be keenly watching how these plans unfold in the coming months.